ENGN
ENGN
NASDAQ · Biotechnology

Engene Holdings Inc

$7.21
-0.01 (-0.07%)
As of Mar 22, 10:18 PM ET ·
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 16 89%
Hold 2 11%
Sell 0 0%
Price Target
Analyst Price Target +806.1% upside
Low Target $48.23
Average Target $65.33
High Target $96.03
Current Price $7.21
Current
$7.21
Target
$65.33
$48.23 $65.33 avg $96.03
Scenario Analysis
Bear Case
$48.23
568.9%
Low target
Base Case
$65.33
+806.1%
Avg target
Bull Case
$96.03
+1,231.9%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$12.25
-41.1% from high
52-Week Low
$2.65
+172.1% from low
Target vs 52W High
$65.33
+433.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%